Global News

[ad_1] Google CEO Sundar Pichai speaks at a panel at the CEO Summit of the Americas hosted by the U.S. Chamber of Commerce on June 09, 2022 in Los Angeles, California. Anna Moneymaker | Getty Images Results were good, but not good enough. That's Wall Street's reaction to quarterly results on Tuesday from Alphabet and Microsoft . Both companies reported revenue and earnings that exceeded estimates, yet the stocks sold off in extended trading. In investor speak, the stocks were priced for perfection. Alphabet shares are up 56% for the year and climbed to a fresh high last week, exceeding the prior record from late 2021, the peak of the tech boom. Microsoft is up 70% over the past 12 months, also reaching a fresh high recently and surpassing Apple as the most valuable publicly traded company. The companies generated excitement last year by riding the artificial intelligence wave, and were also lauded by shareholders for their dramatic cost-cutting efforts, which included ...

[ad_1] A Science employee at work in the lab. Courtesy: Science Corporation Biotechnology startup and Neuralink competitor Science on Monday launched a new platform that aims to make it easier for other companies to quickly develop and produce medical devices.  The platform, called Science Foundry, allows companies to utilize and build upon Science's internal infrastructure by offering access to more than 80 of its tools and services, like the company's thin-film electrode technologies. The cost of the technology required to develop medical devices is often "prohibitive" for early-stage startups, Science Co-Founder and CEO Max Hodak told CNBC in an interview. Individual tools can cost anywhere from $200,000 to $2 million, and Hodak said companies could easily spend hundreds of millions building a manufacturing line.  For many startups, that cost is too much to bear, but Hodak is hoping Science Foundry can help. "Hopefully, we bring down the barriers to innov...

[ad_1] Amazon CEO Andy Jassy doesn't believe the retail and cloud computing giant should be counted out of the artificial intelligence race just yet. In a wide-ranging interview with CNBC, Jassy challenged the notion that Amazon has fallen behind in AI as Microsoft and Google add chatbots to consumer products like their search engines, likening it to the "hype cycle" before the "substance cycle." "I think most people are focused on the applications, you know, things like ChatGPT brought everybody's awareness up, but I think of generative AI as having three macro layers," Jassy told Jon Fortt in an interview that aired on "Closing Bell Overtime" late Thursday. "I think they're all really big and important." Jassy has said Amazon intends to invest in AI across the company, and that AI programs have the potential to improve "virtually every customer experience." But he specifically pointed to Amazon Web Servi...